Now showing items 1-9 of 9

    • Bielke, Lisa; Layton, Sherryll; Hargis, Billy; Pumford, Neil R.; Faulkner, Olivia B.; Berghman, Luc; Abi-Ghanem, Daad (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2019-08-13)
      Vaccine vectors capable of eliciting an immune response to enteric bacteria and methods of using the same are provided. The vaccine vectors include a polynucleotide encoding a PAL polypeptide. The PAL polypeptide may be ...
    • Bielke, Lisa; Layton, Sherryll; Pumford, Neil R.; Faulkner, Olivia B.; Berghman, Luc; Aby-Ghanem, Daad (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2020-07-21)
      Vaccine vectors capable of eliciting an immune response to enteric bacteria and methods of using the same are provided. The vaccine vectors include a polynucleotide encoding a PAL polypeptide. The PAL polypeptide may be ...
    • Bielke, Lisa; Layton, Sherryll; Hargis, Billy; Pumford, Neil R.; Faulkner, Olivia B.; Berghman, Luc; Abi-Ghanem, Daad (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2021-05-25)
      Vaccine vectors capable of eliciting an immune response to enteric bacteria and methods of using the same are provided. The vaccine vectors include a polynucleotide encoding a PAL polypeptide. The PAL polypeptide may be ...
    • Hook,Magnus; Patti, Joseph M.; House-Pompeo, Karen L.; Speziale, Pietro; Joh, Danny; Mcgavin, Martin J. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2004-02-03)
      Disclosed are antibodies that block the binding of fibronectin protein to fibronectin. Also disclosed are site specifically-mutated and truncated peptide epitopes derived from the fnbA and fnbB genes of Staphylococcus ...
    • Hook, Magnus; Patti, Joseph M.; House-pompeo, Karen L.; Speziale, Pietro; Joh, Danny; Mcgavin, Martin J. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2006-10-31)
      Disclosed are antibodies that block the binding of fibronectin protein to fibronectin. Also disclosed are site specifically-mutated and truncated peptide epitopes derived from the fnbA and fnbB genes of Staphylococcus ...
    • Clavijo, Alfonso; Rieder, Aida Elizabeth; Sayed, Abu; Bounpheng, Mangkey A.; Burrage, Thomas G.; Dancho, Brooke A.; Uddowla Blakeney, Sabena (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2018-07-31)
      This disclosure pertains to isolated antibodies or antigen binding fragments thereof that specifically bind to the 3ABC non-structural protein of Foot-and-Mouth Disease virus (FMDV), wherein the antibodies or antigen binding ...
    • Bix, Gregory J. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2015-07-07)
      The disclosed invention relates to the use of perlecan domain V (DV) for the treatment of stroke, traumatic brain injury (TBI) or spinal cord injuries (SCI). In certain embodiments, fusion proteins of DV can be used for ...
    • Ganesh, Vannakambadi K.; Hook, Magnus (United States. Patent and Trademark Office; Texas A&M University. Libraries, 9/20/2022)
      The present invention provides methods and compositions to reduce binding of fibrinogen to the ClfA in a gram positive bacterial infections using monoclonal antibody, a polyclonal antibody, an antigen-binding antibody ...
    • Hook, Magnus; Patti, Joseph M.; House-pompeo, Karen L.; Speziale, Pietro; Joh, Danny; Mcgavin, Martin J. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2012-07-03)
      Disclosed are antibodies that block the binding of fibronectin protein to fibronectin. Also disclosed are site specifically-mutated and truncated peptide epitopes derived from the fnbA and fnbB genes of Staphylococcus ...